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months after radiotherapy was a significant factor for LPFS. 
Patients with CR had higher LPFS rate than the patients 
without CR (88.6% vs. 30.8%, at 5-year, p<0.01). Grade 3 
toxicity was found in 8 patients (5 hematologic, 2 urinary, 
and 1 skeletal) and grade 5 bowel toxicity was found in 1 
patient. 
 
Conclusion: In radical radiotherapy for cervical cancer, EBRT 
can be an option for tumor boost in cases where ICBT cannot 
be performed. Tumor response at 3-6 months after 
radiotherapy was a significant prognostic factor for local 
control.  
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Purpose or Objective: Patients with advanced endometrial 
cancer are a very heterogeneousgroup of patients in which 
theprognosis is influenced by thenumber of extrauterine 
locations,abdominal and nodal spread, typeof surgery, tumor 
residue and histology. 
 
Material and Methods: We studied 47 patients treated with 
SQTWAPI. The FIGOstaging was IIIAin 6 patients, IIIC in 22 and 
IVB in 16. The meanfollow-up for disease-freesurvival (DFS) 
was 32 months.In 26 patients werefound ≤ 3 extrauterine 
locations (≤3LE) and in 21 >3LE. Abdominal spread was 
presentin 26 and was not in 21, negative lymph nodespread in 
11 (G-), positivein 33 (G +) andunknown in 3 (G?). 
Combination of abdominal dissemination and lymph node 
spread (AG) was observed in19 patients, only abdominalin 7 
(SA), single nodal in 17 (SG) and noabdominal or nodal in 4 
(NAG). In 23 ovarian surgery was performed and in 24 it was 
suboptimal.In 8 patients remained tumor residue and 39 did 
not remain. 19 patients hadendometrioid histology and 28 
had a different one. Histological grade 1-2 in 11 and G3 in 36. 
 
Results: The 5-year DFS was respectively:≤3LE patients 
was69% vs 30%in> 3LE (p= 0.0445). Withabdominal spread 
73%vs 35% without(p = 0.05).Group (G-) 90%,group (G+) 47% 
andGroup (G?) 0%, (p = 0.0062).No residue 54%vs 34% (p = 
0.11). Group (AG) 22%, group(SG) 65%, group(SA) 85%,Group 
(NAG) 100% (p = 0.0185). With ovarian protocolsugery 42% 
and without it 62% (p = 0.23). 
 
Conclusion: The number of extrauterine locations, lymph 
node spread, abdominal dissemination and the combination 
of both influenced the SLE. 
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Purpose or Objective: The only imaging modalities without 
pathological confirmation are used to assess lymph node (LN) 
metastases and to perform radiation therapy (RT) planning 
for patients with uterine cervical cancer treated with 
concomitant chemoradiotherapy (CCRT) or RT alone. The aim 
of this study was to evaluate the accuracy of computed 
tomography (CT), magnetic resonance imaging (MRI) and 
positron emission tomography-computed tomography 
(PET/CT) in predicting pelvic LN metastases. 
 
Material and Methods: From January 2009 to March 2015, 
one hundred fifty six patients with International Federation 
of Obstetrics and Gynecology (FIGO) Stage IA1-IIB uterine 
cervical cancer who underwent radical hysterectomy and 
pelvic lymphadenectomy, and CT, MRI and PET/CT before 
surgery were included in this study. The Criteria for LN 
metastases were a LN diameter of 1cm or more at CT and MRI 
and a focally increased FDG uptake greater than SUVmax 3.0 
at PET/CT. The sensitivity, specificity, positive predictive 
value (PPV), negative predictive value (NPV) and accuracy for 
pelvic LN metastases were estimated on the basis of imaging 
and postsurgical pathological findings. Chi square test and 
McNemar's test was used to compare the sensitivity and 
specificity of imaging modalities for the detection of 
metastatic pelvic LN. A P value≤0.05 was considered 
statistically significant. 
 
Results: Among 156 patients, 35 (22%) had pelvic LN 
metastasis on postsurgical pathological findings. There was 
no pelvic LN metastasis for stage IA. The rates of pelvic LN 
metastasis on pathological findings for stage IB, IIA and IIB 
were 19%, 45%, 67%, respectively. The sensitivity, specificity, 
PPV, NPV and accuracy for detection of pelvic LN metastases 
were 48%, 87%, 39%, 91% and 81% for CT; 28%, 97%, 59%, 89% 
and 87% for MRI; and 43%, 90%, 43%, 90% and 83% for PET/CT, 
respectively. The sensitivity was highest for PET/CT, the 
specificity, highest for MRI and the accuracy, highest for MRI. 
The difference between single and multiple metastases on 
image studies to predict LN metastasis was not statistically 
significant (P=0.271). 
 
Conclusion: CT, MRI and PET/CT showed low sensitivity and 
high specificity. The accuracies (greater than 80%) of the 
three imaging modalities were acceptable for RT planning for 
patients treated with CCRT or RT alone. More efforts are 
necessary to improve sensitivity in predicting pelvic LN 
metastases. 
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Purpose or Objective: The outcomes among patients with 
endometrial cancer (EC) are generally favorable. However, 
certain risk factors, such as age, comorbidities, FIGO stage, 
histology type, myometrial infiltration and histology grade, 
may influence survival and prognosis. The aim of this study 
was to analyze the impact of prognostic factors on disease-
free survival (DFS) and overall survival (OS) in patients 
treated with adjuvant radiotherapy. 
 
Material and Methods: We reviewed the records of patients 
diagnosed with EC and received adjuvant radiation therapy. 
The period of recruitment was from January 2001 to 
December 2014. This included epidemiological, clinical and 
treatment characteristics. Statistical analyses, survival 
curves were generated using the Kaplan-Meier technique, and 
differences were tested with the log-rank test. Multivariate 
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analysis of prognostic factors was performed using the Cox 
proportional hazards model and logistic regression analysis. 
 
Results: 155 eligible patients had their data analyzed for this 
work. The median age was 58.7 years (range 31-86). 55 
patients suffered from coexisting comorbidities. All patients 
underwent surgery; a total abdominal hysterectomy plus 
bilateral salpingo-oopherectomy in 92.2%. Lymphadenectomy 
was realized in only 23 patients.They were classified 
according to FIGO stage on (91 I, 24 II, 29 III, 10 IVA). 
Myometrial invasion was > 50 % in 80%. Type1 endometrial 
carcinoma represents the most common type (134 patients). 
Histologic low-grade (G1–2) was found in 77.4%. 154 patients 
received radiotherapy; in 79 cases external beam Radiation 
therapy (EBRT) was associated with vaginal brachytherapy 
(VB). After median follow up of 72 months (2 -144 months) 
loco-regional recurrence occurred in 10 patients (5.1%) and 
metastasis in12 patients (7.7%), the 5-year overall survival 
(OS) and the Disease Free Survival (DFS) was 88,4%, and 
76,1% respectively. DFS was highly significant for: histologic 
type 1vs 2 (p=0.005), histology grade 1-2 vs 3 (p= 0.03) and 
stage I-II vs III-IV (p= 0.04), The addition of VB to EBRT 
revealed statistically significant effect on DFS (p= 0.02).  
 
Conclusion: In our study, tumor’s histology type, grad, and 
FIGO stage are the important prognostic factors and should 
be considered when making treatment decisions. Delivery of 
adjuvant EBRT+VB seems to be a significant independent 
predictor for improved survival and pelvic control. Further 
studies on larger cohorts are necessary for the validation of 
those results. 
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Purpose or Objective: The present study was done to 
evaluate the impact of lymph node on survival outcome of 
cancer cervix treated by chemo-radiotherapy in a tertiary 
care hospital in a northern part of India 
 
Material and Methods: Between Jan 2008- Dec 2011, 300 
cervical cancer patients were registered. Medical records 
were retrieved and documented for various host and 
treatment related parameters and outcomes. Local disease 
free survival (LDFS) and overall survival (OS) was calculated 
from time of registration and computed by Kaplan–Meier 
method. Death due to any cause or loss to follow-up was 
considered as an event for survival analysis i.e. assuming the 
worst case scenario. 
 
Results: Of 300 patients, 72 (24%) did not report after first 
consultation while 64 (21%) were referred for brachytherapy 
from outside medical facilities. For present analysis, 164 
(55%) patients who received treatment with either radical or 
palliative intent in our department were studied. Of 164 
cases, 76%, 15% and 9% presented as de novo cervical cancer, 
post-operative and stump carcinoma respectively. The 
median age (range) at presentation was 52years (26–90), 75% 
were postmenopausal. MRI was preferred pre staging imaging 
modality in half followed by ultrasound .FIGO stage I–IV was 
17%, 37%, 30% and 16% respectively with more than half 
having bulky disease and a third presenting with regional 
lymph nodes and 10% had para-aortic lymph nodes seen on 
imaging at presentation. 93% patients were treated with 
radical while 7% with palliative intent. Two thirds received 
concurrent platin based chemoradiotherapy. Brachytherapy 
was taken by 80% cases. Patients were kept on clinical follow 
up and imaging was done as and when required.  
At the time of analysis 38% are disease free and alive, 21 % 
dead while 40 % were lost to follow-up with or without 
disease. At median follow up of 24 months (0-90), LDFS for 
stage I, II, III and IV was NR (not reached), NR, 17 and 0 
months, p=0.000 while median OS was NR, NR, 17 and 8, 
p=0.000 respectively. The median OS stage-wise with or 
without lymph node presence was - Stage I 27m vs. NR; Stage 
II 46m vs.NR; Stage III 14m vs. 17m and Stage IV 9m vs 2m; 
p=0.000 respectively. Those receiving chemotherapy in 
presence of lymph nodes had a better survival outcome 
median 21m vs 5m p=0.001. 
 
Conclusion: Cervical cancer presented in bulky advanced 
stages with regional and metastatic spread at time of 
presentation. The presence of lymph node decreased survival 
in all stages. The addition of chemotherapy improved survival 
outcome. 
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Purpose or Objective: Synchronous primary endometrial and 
ovarian cancers are infrequent. The objective of this study is 
to evaluate clinicopathological characteristics and treatment 
outcomes of synchronous endometrial and ovarian cancer 
treated in our institution. 
 
Material and Methods: The clinicopathological 
characteristics of 12 patients with synchronous ovarian and 
endometrial cancer treated at SKMCH from July 2005 to July 
2015 were reviewed retrospectively. Their medical records 
and pathology reports were reviewed in depth from hospital 
database. The histologic determination was followed by the 
World Health Organization Committee classification, and 
cancer stage was based on FIGO. 
 
Results: The median age at the time of diagnosis was 50 
years (Range23-66).The incidence of synchronous primary 
endometrial and ovarian cancers was 2.01 % in patients with 
endometrial cancer. A total of 7 patients were menopausal 
(58%), 8 patients were nulliparous (66%) the median BMI was 
29 kg/m2 (range, 20–38). The most common presenting 
symptom was abnormal uterine bleeding. According to FIGO 
stage 10 cases of endometrial were I /II (88%) and 2 cases 
were stage III (16%). Of the ovarian cancers, 9 cases were 
stage I/II 83.3% and 2 cases were stage III (16.7%). 
Endometroid cancer was the main pathological type in 
uterine carcinoma (86%) followed by serous carcinoma (14%) 
and similarly for ovarian cancer endometroid was the most 
common pathology 67 % followed by serous/clear cell 16% 
and mucinous 16.7%. Most endometrial and ovarian primaries 
in our series were grade I and II tumors, 83% and 66% 
respectively. 
8 patients (66%) had similar histology in both primaries while 
4 patients (44%) had different histology. All patients 
underwent surgical intervention. Only one patient did not 
receive any postoperative adjuvant therapy. 10 patients 
received platinum-based adjuvant chemotherapy and six 
patients received adjuvant radiotherapy 
 
Conclusion: Synchronous primary endometrial and ovarian 
cancers are infrequent and distinct set of patients. Abnormal 
PV bleed was the most common symptom which helped in 
early detection. Majority of the patients belong to 
concordant endometroid histology, low grade, had younger 
age and High BMI. Treatment should be tailored to the stage, 
histology, and grade of the individual tumors. 
 
 
 
 
